Please assess the completion status of the following clinical trial:

Trial Title: Acute Cardioversion Versus Wait And See-approach for Symptomatic Atrial Fibrillation in the Emergency Department

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* ECG with atrial fibrillation at the emergency department~* Heart rate \> 70bpm~* Symptoms most probable due to atrial fibrillation~* Duration of symptoms \< 36 hours~* \> 18 years of age~* Able and willing to sign informed consent~* Able and willing to use MyDiagnostick~Exclusion Criteria:~* Signs of myocardial infarction on ECG~* Hemodynamic instability (systolic blood pressure \< 100mm Hg, heart rate \> 170 bpm)~* Presence of pre-excitation syndrome~* History of Sick Sinus Syndrome~* History of unexplained syncope~* History of persistent AF (episode of AF lasting more than 48 hours)~* Acute heart failure~* Currently enrolled in another clinical trial~* Deemed unsuitable for participation by attending physician

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Standard Care (Type: ACTIVE_COMPARATOR): Pharmacological cardioversion and/or electrical cardioversion
- Wait-and-see Approach (Type: EXPERIMENTAL): Rate control drugs only (metoprolol, verapamil or digoxin)

Based on this trial design, predict the completion outcome and termination type (if applicable).